Write a review
Reviews: 0
Manufacturers: Dr. Willmar Schwabe Gmbh & Co
Active ingredients
- Not indicated. See instructions
Disease class
- Varicose veins
- Venous insufficiency (chronic) (peripheral)
- Other and unspecified circulatory system disorders
- Cramp and spasm
- Localized swelling
Clinical and pharmacological group
- Not indicated. See instructions
Pharmacological action
- Anti-inflammatory
- Antiexudative
- Venotonic
- Angioprotective
- Decongestant
Pharmacological group
- Angioprotectors and microcirculation correctors
Venoplant oral tablets
Instructions for medical use of the drug
Description of pharmacological action
Reduces capillary permeability, has a venotonic, decongestant, anti-inflammatory and angioprotective effect. Prevents the activation of lysosomal enzymes that break down proteoglycan, increases the tone of the venous wall, eliminates venous stagnation, reduces the permeability and fragility of capillaries. Reduces exudation, reduces the effusion of fluid into the tissue and accelerates the resorption of existing edema. Inhibits inflammation processes, improves microcirculation, promotes repair of organs and tissues.
Indications for use
Symptomatic treatment of diseases of the veins of the lower extremities (including varicose veins), characterized by chronic venous insufficiency, with symptoms such as pain and a feeling of heaviness in the legs, night cramps of the calf muscles, itching and swelling of the legs.
Release form
film-coated tablets, prolonged action 263.2 mg; blister 20, cardboard pack 1; film-coated tablets, prolonged action 263.2 mg; blister 25, cardboard pack 2; film-coated tablets, prolonged action 263.2 mg; blister 25, cardboard pack 4; film-coated tablets, prolonged action 263.2 mg; blister 10, cardboard pack 4; film-coated tablets, prolonged action 263.2 mg; blister 10, cardboard pack 2; film-coated tablets, prolonged action 263.2 mg; blister 20, cardboard pack 2; film-coated tablets, prolonged action 263.2 mg; blister 20, cardboard pack 4;
Use during pregnancy
Not recommended during pregnancy and lactation due to the lack of clinical data.
Contraindications for use
Hypersensitivity to any of the components of the drug. With caution: - simultaneous use with indirect anticoagulants; - age under 18 years (efficacy and safety have not been studied).
Side effects
Allergic reactions: feeling of heat, urticaria, skin rash, itching, rarely - anaphylactic shock, dyspepsia (including nausea). If any adverse events occur, you should stop taking the drug and consult your doctor.
Directions for use and doses
Orally, before meals, morning and evening, without chewing, with a small amount of liquid. 1 table each 2 times a day; The duration of treatment is determined by the severity of the symptoms of the disease. Long-term use is acceptable.
Overdose
No cases of overdose have been reported to date. Treatment: in case of overdose, consult a doctor
Interactions with other drugs
Strengthens the effect of indirect anticoagulants.
Special instructions for use
The effectiveness and safety of the drug in children have not been studied, so prescribing the drug to children is not recommended. It is necessary to strictly follow the additional instructions of the doctor - bandaging the feet, wearing elastic stockings, cold foot baths! If severe symptoms suddenly appear (especially in one leg), such as severe swelling, changes in skin color, a feeling of tension and heat, pain, you should immediately consult a doctor. These symptoms may be symptoms of a serious disease - thrombosis of the veins of the lower extremities.
Storage conditions
List B.: At a temperature of 15–25 °C.
Best before date
36 months
ATX classification:
C Cardiovascular system
C05 Angioprotectors
C05C Drugs that reduce capillary permeability
C05CX Other drugs that reduce capillary permeability
Venoplant 263.2 mg n20 extended-release film-coated tablets
Latin name
Venoplant
Release form
Pills
Package
20 pcs.
pharmachologic effect
Venoplant reduces capillary permeability, has a venotonic, decongestant, anti-inflammatory and angioprotective effect.
Pharmacodynamics
Reduces capillary permeability, has a venotonic, decongestant, anti-inflammatory and angioprotective effect.
Prevents the activation of lysosomal enzymes that break down proteoglycan, increases the tone of the venous wall, eliminates venous stagnation, reduces the permeability and fragility of capillaries.
Reduces exudation, reduces the effusion of fluid into the tissue and accelerates the resorption of existing edema.
Inhibits inflammation processes, improves microcirculation, promotes repair of organs and tissues.
Pharmacokinetics
Dry horse chestnut seed extract contains a large number of biologically active substances, which together determine its pharmacological activity. Therefore, data on the pharmacokinetics of individual chemical components included in the extract are insufficient for extrapolation to the drug as a whole.
Indications
Chronic venous insufficiency class I–III according to the CEAP classification: varicose veins, swelling, cramps in the calf muscles, a feeling of heaviness in the legs.
Contraindications
Hypersensitivity to horse chestnut seed extract or any of the components of the drug; children's age (up to 18 years).
Use during pregnancy and breastfeeding
Use during pregnancy and lactation is not recommended due to the lack of experimental data on use.
special instructions
It is necessary to strictly follow all additional doctor's instructions - leg bandaging, wearing elastic stockings, cold foot baths. All regulations must be strictly observed.
If severe symptoms suddenly appear (especially on one leg), such as severe swelling, change in skin color, feeling of tension, heat, pain, you should immediately consult a doctor, because they can be symptoms of a serious disease - thrombosis of the veins of the lower extremities.
Impact on the ability to drive vehicles and operate machinery.
During the period of use of the drug, caution should be exercised when performing potentially hazardous activities that require increased attention and speed of psychomotor reactions.
Compound
1 tablet contains:
Active substance: horse chestnut seed extract dry (4.5–5.5:1) (standardized by the amount of triterpene glycosides in terms of anhydrous escin - 50 mg) 263.2 mg;
Excipients: calcium hydrogen phosphate anhydrous - 36.8 mg; colloidal silicon dioxide - 15.4 mg; crospovidone - 10 mg; magnesium stearate - 2 mg; Eudragit RL 30 D – 14 mg; Eudragit RS 30 D - 10 mg; povidone K25 - 20 mg; polysorbate 80 - 0.036 mg; triethyl citrate - 3.564 mg;
Film shell: vanillin - 0.405 mg; hypromellose - 11.33 mg; iron oxide red (E172) - 0.22 mg; iron oxide yellow (E172) - 1.09 mg; macrogol 4000 - 5.67 mg; sodium saccharinate - 0.025 mg; titanium dioxide (E171) - 0.68 mg; defoaming emulsion - 0.01 mg; talc - 1 mg; titanium dioxide - 0.68 mcg.
Directions for use and doses
Orally, before meals, morning and evening, without chewing, with a small amount of liquid. 1 table each Venoplant 2 times a day.
Side effects
Allergic reactions:
feeling of heat, urticaria, skin rash, itching, rarely - anaphylactic shock, dyspepsia (including nausea).
Drug interactions
Venoplant enhances the effect of indirect anticoagulants.
Overdose
Cases of drug overdose have not been reported to date. In case of overdose, you should consult a doctor, who should decide on the necessary actions.
Storage conditions
Store at temperatures from +15 °C to +25 °C, out of the reach of children.
Best before date
3 years
Similar drugs:
- Dolobene Gel for external use
- Wobenzym Oral tablets
- Diacarb Oral tablets
- Hydrocortisone Substance-powder
- Lipril (Liprilum) Oral tablets
- Soventol Gel
- Feloran Gel for external use
- Lyoton 1000 Gel for external use
- Indovasin Gel for external use
- Indomethacin (Indometacinum) Oral tablets
** The Drug Directory is intended for informational purposes only. For more complete information, please refer to the manufacturer's instructions. Do not self-medicate; Before starting to use the drug Venoplant, you should consult a doctor. EUROLAB is not responsible for the consequences caused by the use of information posted on the portal. Any information on the site does not replace medical advice and cannot serve as a guarantee of the positive effect of the drug.
Are you interested in the drug Venoplant? Do you want to know more detailed information or do you need a doctor's examination? Or do you need an inspection? You can make an appointment with a doctor - the Euro lab is always at your service! The best doctors will examine you, advise you, provide the necessary assistance and make a diagnosis. You can also call a doctor at home . Euro lab clinic is open for you around the clock.
** Attention! The information presented in this medication guide is intended for medical professionals and should not be used as a basis for self-medication. The description of the drug Venoplant is provided for informational purposes and is not intended for prescribing treatment without the participation of a doctor. Patients need to consult a specialist!
If you are interested in any other drugs and medications, their descriptions and instructions for use, information about the composition and form of release, indications for use and side effects, methods of use, prices and reviews of drugs, or you have any other questions and suggestions - write to us, we will definitely try to help you.
Venoplant®
Manufacturer: Dr. WILLMAR SCHWABE GmbH & Co.KG (Germany)
◊ tab. prolong. actions, covering coated, 50 mg: 20, 40, 50, 80 or 100 pcs. Reg. No.: P N016082/01
Clinical and pharmacological group:
Herbal medicine used for venous circulation disorders
Release form, composition and packaging
◊ Extended-release film-coated tablets
light brown, round, biconvex; the fracture shows a light brown shell and a brown to light brown core.
| 1 tab. | |
| escin anhydrous | 50 mg |
| dry extract of horse chestnut seeds (4.5-5.5:1) 263.2 mg, |
Excipients:
anhydrous calcium hydrogen phosphate, colloidal silicon dioxide, Eudragit RL 30D (poly copolymer (ethacrylate:methyl acrylate:trimethylammonioethyl methacrylate chloride) 1:2:0.2; sorbic acid), Eudragit RS 30D (poly copolymer (ethacrylate:methyl acrylate:trimethylammonioethyl methacrylate chloride) 1:2: 0.1; sorbic acid), triethyl citrate, polysorbate 80, povidone K25, crospovidone, magnesium stearate, hypromellose (5 mPa x s), macrogol 4000, iron oxide red (E172), iron oxide yellow (E172), titanium dioxide, talc, sodium saccharin, vanillin, defoaming emulsion.
* extractant: ethanol 50 wt.%
10 pieces. - blisters (2) - cardboard packs. 10 pieces. - blisters (4) - cardboard packs. 20 pcs. - blisters (2) - cardboard packs. 20 pcs. - blisters (4) - cardboard packs. 25 pcs. - blisters (2) - cardboard packs. 25 pcs. - blisters (4) - cardboard packs.
Description of the active components of the drug "Venoplant"
pharmachologic effect
A herbal medicine used for venous circulation disorders. It has a venotonic, decongestant, anti-inflammatory and angioprotective effect. Prevents the activation of lysosomal enzymes that break down proteoglycan, increases the tone of the veins, eliminates venous congestion, reduces the permeability and fragility of capillaries. Reduces exudation, reduces the effusion of fluid into the tissue and accelerates the resorption of existing edema. Inhibits inflammation processes, improves microcirculation, promotes repair of organs and tissues.
Indications
- symptomatic treatment of diseases of the veins of the lower extremities (including varicose veins, chronic venous insufficiency, accompanied by pain and a feeling of heaviness in the legs, night cramps of the calf muscles, skin itching and swelling).
Dosage regimen
The drug is prescribed 1 tablet. 2 times/day, morning and evening before meals.
The tablets should be taken whole, without chewing, with a small amount of liquid.
The duration of taking the drug is determined by the severity of the symptoms of the disease and can be quite long.
Side effect
From the digestive system:
dyspepsia (including nausea).
Allergic reactions:
feeling of heat, urticaria, skin rash, itching; rarely - anaphylactic shock.
Contraindications
- hypersensitivity to the components of the drug.
Carefully _
the drug should be prescribed simultaneously with indirect anticoagulants to patients under 18 years of age (since the safety and effectiveness of the drug have not been studied).
Pregnancy and lactation
Due to the lack of data, it is not recommended to use Venoplant during pregnancy and lactation.
Application for children
Carefully _
The drug should be prescribed to patients under the age of 18 years (since the safety and effectiveness of the drug have not been studied).
special instructions
The patient should be informed about the need to perform additional measures, such as bandaging the feet, wearing elastic stockings, and using cool foot baths.
If severe symptoms suddenly appear (especially in one leg), such as swelling, change in skin color, feeling of heat and tension, pain, the patient should immediately consult a doctor, because the development of thrombosis of the veins of the lower extremities is possible.
Use in pediatrics
The effectiveness and safety of Venoplant in children have not been studied, so it is not recommended to prescribe the drug to this category of patients.
Overdose
Currently, no cases of overdose of Venoplant have been reported.
Drug interactions
When used simultaneously, Venoplant enhances the effect of indirect anticoagulants.
Conditions for dispensing from pharmacies
The drug is approved for use as a means of OTC.
Storage conditions and periods
List B. The drug should be stored out of the reach of children at a temperature of 15° to 25°C. Shelf life: 3 years.
Drug interactions
When used simultaneously, Venoplant enhances the effect of indirect anticoagulants.
